Actualités

Healthcare apparel company Figs (NYSE:FIGS) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 28.8% year on year to $196.6 million. Its GAAP profit of $0.15 per share was significantly above analysts’ consensus estimates.

SHAK's Q2 earnings beat estimates and revenues rose 17.2% YoY, but beef inflation and higher costs pressured margins.

BROS tops Q2 estimates with strong comps and expansion, lifts 2026 outlook as new shops and traffic growth fuel momentum.

FIGS heads into Q2 earnings with product innovation, global expansion and demand momentum in focus, while tariffs and freight costs may have pressured margins.

Capri Holdings (CPRI) delivered earnings and revenue surprises of +67.50% and +2.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MCD's Q2 earnings beat estimates as stronger franchised margins offset a revenue miss, while comparable sales rise across all three segments.

Since January 2026, Figs has been in a holding pattern, posting a small loss of 0.5% while floating around $10.75. The stock also fell short of the S&P 500’s 7.1% gain during that period.

CMG's second-quarter results reflect benefits from positive comparable sales, restaurant expansion and stronger digital engagement.

YUM tops earnings estimates as Taco Bell's strong sales and global expansion help offset softer Pizza Hut performance.

BLDR stock is down after second-quarter earnings and sales miss estimates, with weaker housing demand and a lower 2026 outlook adding to investor concerns.

SBUX's shares jump after fiscal third-quarter adjusted earnings beat estimates, comparable sales rise and management lifts fiscal 2026 guidance.

DPZ's fiscal second-quarter results reflect benefits from order growth across both delivery and carryout channels.

FIGS stock has returned 77.6% over the past year, yet the valuation checks are sending mixed signals as the Discounted Cash Flow (DCF) intrinsic value estimate points to some upside while earnings based multiples lean the other way. Over the last 12 months FIGS has delivered a 77.6% share price gain, which puts added focus on whether that rerating is backed up by fundamentals. Recent optimism around earnings prospects, highlighted by an analyst upgrade, can support the intrinsic value case...

FIGS' record-high net revenues per active customer signal stronger spending, higher purchase frequency and engagement as the company lifts its 2026 outlook.

Figs (FIGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

FIGS shows how healthcare apparel is evolving through essential demand, broader wardrobes, Community Hubs and global growth, despite cost friction.

FIGS' stronger revenue outlook and customer growth support the bull case, but its big rally, richer valuation and cost pressure complicate the buy call.

FIGS' outlook rests on scrubwear strength, rising active customers and a global push, even as tariffs, freight and marketing spending pressure margins.

An analyst maintained her bullish stance on the company following discussions with two executives.

Looking back on consumer discretionary - apparel and accessories stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Figs (NYSE:FIGS) and its peers.

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

A number of stocks jumped in the afternoon session after oil prices fell on hopes of a US-Iran peace deal.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

If you are wondering whether FIGS at US$11.66 is offering good value or just pricing in a lot of optimism, the next steps are all about putting some structure around that question. The stock has returned 2.0% over the last week, 0.3% over the past month, 2.4% year to date, 124.2% over the last year, 34.8% over three years and a decline of 65.7% over five years, giving you a mix of strong recent gains and a longer term reset to think about. Recent headlines have focused on FIGS as a...

In early June 2026, FIGS reported quarterly results that surpassed analyst expectations, highlighting broad-based sales growth, improving margins, and strong cash flow across its healthcare apparel business. These results underline how FIGS’ product innovation and disciplined operations are supporting both reinvestment in growth initiatives and ongoing returns to shareholders. Now we’ll explore how this stronger-than-expected profitability performance may reshape FIGS’ existing investment...

One company powers healthcare apparel with direct sales and rapid growth, while the other scales global basics with steady cash flow and lower valuations.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.